Targeted next-generation sequencing of 565 neuro-oncology patients at UCLA: a single-institution experience
MS Ji, BSC Eldred, R Liu, ST Pianka… - Neuro-Oncology …, 2020 - academic.oup.com
Background Targeted next-generation sequencing (NGS) is frequently obtained at the
University of California, Los Angeles (UCLA) for clinical characterization of CNS tumors. In
this study, we describe the diagnostic reliability of the Foundation Medicine (FM) targeted
NGS platform and its ability to explore and identify tumor characteristics of prognostic
significance in gliomas. Methods Neuro-oncology patients seen at UCLA who have received
FM testing between August 2012 and March 2019 were included in this study, and all …
University of California, Los Angeles (UCLA) for clinical characterization of CNS tumors. In
this study, we describe the diagnostic reliability of the Foundation Medicine (FM) targeted
NGS platform and its ability to explore and identify tumor characteristics of prognostic
significance in gliomas. Methods Neuro-oncology patients seen at UCLA who have received
FM testing between August 2012 and March 2019 were included in this study, and all …
以上显示的是最相近的搜索结果。 查看全部搜索结果